Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.

We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...

The drug is approved for long-term weight management and also helps reduce the risk of major cardiovascular events in people ...

Wegovy, which is a prescription medicine is indicated to help manage weight and lower the risk of serious heart-related ...

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve ...

Wegovy is a prescription-only medication that has the potential to improve the quality of life for millions of Indians living ...

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular events in individuals with established heart disease.

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in ...

Ozempic and Mounjaro may also lower your risk of obesity-linked cancer A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.